Literature DB >> 26721669

Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women.

Traci N Bethea1, Lynn Rosenberg2, Nelsy Castro-Webb2, Kathryn L Lunetta3, Lara E Sucheston-Campbell4, Edward A Ruiz-Narváez2, Marjory Charlot5, Song-Yi Park6, Elisa V Bandera7, Melissa A Troester8, Christine B Ambrosone4, Julie R Palmer2.   

Abstract

BACKGROUND: The evidence on the relation of family history of cancers other than breast cancer to breast cancer risk is conflicting, and most studies have not assessed specific breast cancer subtypes.
METHODS: We assessed the relation of first-degree family history of breast, prostate, lung, colorectal, ovarian, and cervical cancer and lymphoma or leukemia, to the risk of estrogen receptor-positive (ER(+)), ER(-), and triple-negative breast cancer in data from the African American Breast Cancer Epidemiology and Risk Consortium. Multivariable logistic regression models were used to calculate ORs and 95% confidence intervals (CI).
RESULTS: There were 3,023 ER(+) and 1,497 ER(-) breast cancer cases (including 696 triple-negative cases) and 17,420 controls. First-degree family history of breast cancer was associated with increased risk of each subtype: OR = 1.76 (95% CI, 1.57-1.97) for ER(+), 1.67 (1.42-1.95) for ER(-), and 1.72 (1.38-2.13) for triple-negative breast cancer. Family history of cervical cancer was associated with increased risk of ER(-) (OR = 2.39; 95% CI, 1.36-4.20), but not ER(+) cancer. Family history of both breast and prostate cancer was associated with increased risk of ER(+) (3.40; 2.42-4.79) and ER(-) (2.09; 1.21-3.63) cancer, but family history of both breast and lung cancer was associated only with ER(-) cancer (2.11; 1.29-3.46).
CONCLUSIONS: A family history of cancers other than breast may influence the risk of breast cancer, and associations may differ by subtype. IMPACT: Greater surveillance and counseling for additional screening may be warranted for women with a family history of cancer. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26721669      PMCID: PMC4767636          DOI: 10.1158/1055-9965.EPI-15-1068

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  76 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Familial resemblance for anthropometric measurements and relative fat distribution among African Americans.

Authors:  C Rotimi; R Cooper
Journal:  Int J Obes Relat Metab Disord       Date:  1995-12

3.  Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry.

Authors:  M F Jishi; J H Itnyre; I A Oakley-Girvan; M S Piver; A S Whittemore
Journal:  Cancer       Date:  1995-10-15       Impact factor: 6.860

4.  Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.

Authors:  Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2011-06-11       Impact factor: 4.872

5.  Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Paul F Pinsky; Barnett S Kramer; Douglas Reding; Saundra Buys
Journal:  Am J Epidemiol       Date:  2003-05-01       Impact factor: 4.897

6.  Association of body fat distribution and family histories of breast and ovarian cancer with risk of postmenopausal breast cancer.

Authors:  T A Sellers; S M Gapstur; J D Potter; L H Kushi; R M Bostick; A R Folsom
Journal:  Am J Epidemiol       Date:  1993-11-15       Impact factor: 4.897

7.  Breast cancer risk factors among black women and white women: similarities and differences.

Authors:  R M Mayberry; C Stoddard-Wright
Journal:  Am J Epidemiol       Date:  1992-12-15       Impact factor: 4.897

8.  Familial correlation of dietary intakes among postmenopausal women.

Authors:  C M Vachon; T A Sellers; L H Kushi; A R Folsom
Journal:  Genet Epidemiol       Date:  1998       Impact factor: 2.135

9.  Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women.

Authors:  Kristin Anderson; Patricia A Thompson; Betsy C Wertheim; Lorena Martin; Ian K Komenaka; Melissa Bondy; Adrian Daneri-Navarro; Maria Mercedes Meza-Montenegro; Luis Enrique Gutierrez-Millan; Abenaa Brewster; Lisa Madlensky; Malaika Tobias; Loki Natarajan; María Elena Martínez
Journal:  Springerplus       Date:  2014-12-11

10.  Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women.

Authors:  Christine B Ambrosone; Gregory L Ciupak; Elisa V Bandera; Lina Jandorf; Dana H Bovbjerg; Gary Zirpoli; Karen Pawlish; James Godbold; Helena Furberg; Anne Fatone; Heiddis Valdimarsdottir; Song Yao; Yulin Li; Helena Hwang; Warren Davis; Michelle Roberts; Lara Sucheston; Kitaw Demissie; Kandace L Amend; Paul Tartter; James Reilly; Benjamin W Pace; Thomas Rohan; Joseph Sparano; George Raptis; Maria Castaldi; Alison Estabrook; Sheldon Feldman; Christina Weltz; Margaret Kemeny
Journal:  J Oncol       Date:  2009-10-25       Impact factor: 4.375

View more
  4 in total

1.  Alcohol Intake and Breast Cancer Risk in African American Women from the AMBER Consortium.

Authors:  Lindsay A Williams; Andrew F Olshan; Chi-Chen Hong; Elisa V Bandera; Lynn Rosenberg; Ting-Yuan David Cheng; Kathryn L Lunetta; Susan E McCann; Charles Poole; Laurence N Kolonel; Julie R Palmer; Christine B Ambrosone; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-04-18       Impact factor: 4.254

2.  Breast Cancer Incidence and Mortality by Molecular Subtype: Statewide Age and Racial/Ethnic Disparities in New Jersey.

Authors:  Aishwarya Kulkarni; Antoinette M Stroup; Lisa E Paddock; Stephanie M Hill; Jesse J Plascak; Adana A M Llanos
Journal:  Cancer Health Disparities       Date:  2019-08-19

3.  Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium.

Authors:  Hazel B Nichols; Mariaelisa Graff; Jeannette T Bensen; Kathryn L Lunetta; Katie M O'Brien; Melissa A Troester; Lindsay A Williams; Kristin Young; Chi-Chen Hong; Song Yao; Christopher A Haiman; Edward A Ruiz-Narváez; Christine B Ambrosone; Julie R Palmer; Andrew F Olshan
Journal:  Breast Cancer Res Treat       Date:  2020-09-22       Impact factor: 4.872

4.  Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.

Authors:  Iván Márquez-Rodas; Marina Pollán; María José Escudero; Amparo Ruiz; Miguel Martín; Ana Santaballa; Purificación Martínez Del Prado; Norberto Batista; Raquel Andrés; Antonio Antón; Antonio Llombart; Antonio Fernandez Aramburu; Encarnación Adrover; Sonia González; Miguel Angel Seguí; Lourdes Calvo; José Lizón; Álvaro Rodríguez Lescure; Teresa Ramón Y Cajal; Gemma Llort; Carlos Jara; Eva Carrasco; Sara López-Tarruella
Journal:  PLoS One       Date:  2017-10-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.